Dr Michael J. Strong has been appointed the new president of the Canadian Institutes of Health Research (CIHR) effective October 1.
Person: Michel Perron
John Molloy
John Molloy has been appointed executive chairman of ABcann Medicinals, a Napanee ON-based developer and grower of medical marijuana. Molloy was president and CEO of PARTEQ Innovations — the technology transfer arm of Queen’s Univ — for more than 27 years before stepping down last year (R$, June 21/13). (He was replaced on a permanent…
Michel Perron
Michel Perron has been appointed VP external affairs and business development at the Canadian Institutes of Health Research (CIHR), replacing Dr Robert Thirsk who retired in February. Perron comes to CIHR from the Canadian Centre on Substance Abuse where he has served as CEO since 1999. He will be responsible for all matters relating to…
Dr Peter Lewis
Dr Peter Lewis has been appointed interim VP research and innovation of the Univ of Toronto, effective July 1. Lewis has been the university’s associate VP research and innovation specializing in global research partnerships since 2010. He takes on the interim VP position following the departure of Dr Paul Young to return as a full…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...